Löbke et al., Proteomics 2008
(Breast Neoplasms) :
Activation of ERK1/2 and AKT by ERBB1 ( EGFR ), ERRB2 ( HER2/neu ), and ERBB3-4 was monitored in a time resolved manner
Vlotides et al., Cancer Res 2009
(Pituitary Neoplasms...) :
Heregulin ( 6 nmol/L ) induced tyrosine phosphorylation and ErbB3 and p185 ( c-neu ) heterodimerization, with subsequent activation of intracellular ERK and Akt